Among individuals with chronic kidney disease, the presence of anemia doubled the risk for hyperuricemia.
Among individuals with chronic kidney disease, the presence of anemia doubled the risk for hyperuricemia.
In this post hoc analysis, researchers explored whether anemia was a predictor of radiographic progression in patients with RA who were treated with tofacitinib.
Other biologic DMARDs were not associated with any significant clinically meaningful increase in Hb and Hct levels.